Join the club for FREE to access the whole archive and other member benefits.

Sean Lybrand

Executive Director of International Health Systems at Amgen

- Experienced, results-focused access and policy leader, demonstrating success at local, regional and global levels across different cultural contexts. 

- Driven by the central premise that pharmaceutical companies are partners in the improvement of health outcomes, along with payers, advocacy organisations, and consumers

- Highly competent in pharmaceutical and vaccine access issues, pricing and reimbursement activities, policy and advocacy engagement, and industry representation, and how these translate into positive stakeholder outcomes

- Strong cross-functional and team leadership ability - ensuring that the broader team is committed to the goals of improved access to medicines

- Country Leadership Team experience in guiding strategic direction of subsidiary and building the presence and capabilities of a biopharmaceutical company in multiple therapeutic areas

Visit website: https://biography.omicsonline.org/australia/amgen/sean-lybrand-488410

 seanlybrand

See also: Company Amgen - Biotechnology company that develops and manufactures human therapeutics for various illness and diseases

Details last updated 18-Mar-2022

Sean Lybrand is also referenced in the following:

Global launch: Delivering prevention in an ageing world

07-Apr-2022

Event about prevention in an ageing organized by International Longevity Centre UK